Document:

EX-10.30

 Exhibit 10.30 

REGENX BIOSCIENCES, LLC 

BOARD OF MANAGERS AGREEMENT 

This BOARD OF MANAGERS AGREEMENT (this “Agreement”) is made and entered into as of February 6, 2013 by and between
ReGenX Biosciences, LLC, a Delaware limited liability company (“ReGenX”), and Mr. Don Hayden, an individual (the “Manager”). ReGenX and the Manager are referred to herein together as the
“Parties.” 
 RECITAL 

ReGenX desires that the Manager become a member of its Board of Managers, and the Manager desires to become a member of the Board of Managers
of ReGenX. 
 AGREEMENT 
 In
consideration of the mutual covenants below, and intending to be legally bound, the Parties hereby agree as follows: 
 1. Board of
Managers. ReGenX hereby retains the Manager, and the Manager hereby agrees to serve, as a member of the Board of Managers of ReGenX. As a member of the Board of Managers, the Manager shall devote his efforts to satisfying the responsibilities,
and shall have the powers and be entitled to the rights, of a member of the Board of Managers as set forth in ReGenX’s Fifth Amended and Restated Limited Liability Company Agreement (a copy of which has been provided to the Manager), as such
agreement may be amended from time to time. 
 2. Compensation and Expenses. 

(a) As compensation for the Manager’s service on the Board of Managers, ReGenX will (i) pay the Manager an annual fee of $40,000,
payable within ten days after the execution of this Agreement and thereafter on each anniversary date of the date of this Agreement so long as the Manager serves on the Board of Managers, and (ii) grant to the Manager an equity incentive
consisting of 6,420,000 Class B Units of ReGenX. It is understood by the Manager that ReGenX is in the process of raising equity capital through the sale of Preferred Units and ReGenX wishes to compensate the Manager for the dilution caused by such
sale. Accordingly in the event that (i) ReGenX closes a sale of Preferred Units on or before December 31, 2013 and (ii) the Manager remains a member of the Board of Managers of ReGenX at the time of such sale then, no later than
promptly following such sale, ReGenX will grant the Manager such number of additional shares of Class B Units of ReGenX as is necessary to maintain Manager’s 2.5% equity interest in ReGenX, on a fully diluted basis. The terms and conditions of
the Class B Units and the grant are governed by the ReGenX Fifth Amended and Restated Limited Liability Company Agreement, the ReGenX 2009 Equity Incentive Plan and the Manager’s Class B Equity Interest Award Agreement, a copy of each of which
has been provided to the Manager. 
 (b) ReGenX will also reimburse or cause one or more of its affiliates to reimburse the Manager for all
reasonable travel and other expenses preapproved by ReGenX that 

 
the Manager incurs in connection with the services the Manager will provide to ReGenX. Reimbursements will be made in accordance with ReGenX’s policies and procedures for reimbursement,
including the delivery to ReGenX of appropriate expense vouchers or other documentation. 
 3. Recognition of ReGenX’s Rights;
Nondisclosure. 
 (a) At all times during the term of the Manager’s association with ReGenX and thereafter, the Manager shall
hold in strictest confidence and shall not disclose, use, lecture upon or publish any of ReGenX’s Proprietary Information (defined below), except to the extent such disclosure, use or publication may be required in direct connection with the
Manager’s performance for ReGenX as a member of the Board of Managers or is expressly authorized in writing by an officer of ReGenX. 

(b) The term “Proprietary Information” shall mean any and all trade secrets, confidential knowledge, know-how, data or other
proprietary information or materials of ReGenX. By way of illustration but not limitation, Proprietary Information includes: (i) inventions, ideas, samples, media and/or viral vectors and procedures and formulations for producing any such
samples, media and/or viral vectors, processes, formulas, data, know-how, improvements, discoveries, developments, designs and techniques; (ii) information regarding plans for research, development, new products, marketing and selling, business
plans, budgets and unpublished financial statements, licenses, prices and costs, suppliers and customers; (iii) information regarding the skills and compensation of employees or other consultants of ReGenX; and (iv) the compensation of the
Manager and the terms and conditions of this Agreement. Notwithstanding the foregoing “Proprietary Information” shall not include information that the Manager can demonstrate by competent evidence: 

(i) is known by the Manager prior to receipt from ReGenX; 

(ii) is hereafter disclosed to the Manager by a third party having no obligation of confidentiality to ReGenX; 

(iii) is available to the public at the time of the Manager’s receipt from ReGenX; 

(iv) subsequently becomes available to the public through no fault of the Manager; or 

(v) is developed by the Manager independently of the Proprietary Information provided by ReGenX. 

(c) In addition, the Manager understands that ReGenX has received and in the future will receive from third parties confidential or
proprietary information (“Third Party Information”) subject to a duty on the part of ReGenX to maintain the confidentiality of such information and to use it only for certain limited purposes. During the term of the Manager’s
association with ReGenX and thereafter, the Manager shall hold all Third Party Information in the strictest confidence and shall not disclose or use Third Party Information, except as required in direct connection with the Manager’s performance
for ReGenX as a Board member or as expressly authorized in writing by an officer of ReGenX. 

  
 2 

 4. Return of Documents. At the written request of ReGenX, the Manager shall return to
ReGenX any and all materials and physical documents, whether prepared by ReGenX or its affiliates or by the Manager, if such materials or documents include or incorporate in any way Proprietary Information. The term document is used in its broadest
sense and includes electronic information in the form of discs, tapes and the like. 
 5. No License. No rights or licenses in or to
Proprietary Information are granted to the Manager by virtue of this Agreement. 
 6. No Improper Use of Materials. The Manager
agrees not to bring to ReGenX or to use in the performance of services for ReGenX under this Agreement any materials or documents of a present or former employer of the Manager, or any materials or documents that the Manager obtained from a third
party under a binder of confidentiality, unless such materials or documents are generally available to the public or the Manager has authorization from such present or former employer or third party for the possession and unrestricted use of such
materials. The Manager understands that the Manager is not to breach any obligation of confidentiality that the Manager has to present or former employers or clients, and agrees to fulfill all such obligations during the term of the Manager’s
service on the Board of Managers. 
 7. Miscellaneous. This Agreement constitutes the entire and exclusive agreement between the
Manager and ReGenX with respect to the subject matter hereof and supersedes any prior or contemporaneous agreements, representations and understandings of the parties with respect thereto. No supplement, modification or amendment of the arrangement
described in this Agreement shall be binding upon the Manager or ReGenX or unless set forth in a writing and executed by the Manager and ReGenX. The obligations described under Sections 3, 4 and 6 shall survive the termination of this Agreement.
This Agreement and the obligation hereunder shall not be assignable, except that ReGenX may assign this Agreement and the obligations hereunder to any person or entity acquiring all or substantially all of the assets of ReGenX or the assets used in
the Business. This Agreement shall be governed by the laws of the State of Delaware without regard to any otherwise applicable principles of conflicts of law. 

[signature page follows] 

  
 3 

 IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first written
above. 
 REGENX BIOSCIENCES, LLC 
  

							
	By:	  	 /s/ Kenneth T. Mills
	 		 	 /s/ Don Hayden

	Name:	  	Kenneth T. Mills	 		 	Mr. Don Hayden
	Title:	  	President & CEOExhibit

EXHIBIT 10.1

SECOND AMENDMENT TO MANAGEMENT AGREEMENT

THIS AMENDMENT, effective as of July 1, 2015, by and among INVESCO MORTGAGE CAPITAL INC., a Maryland corporation (the “Company”), IAS OPERATING PARTNERSHIP LP, a Delaware limited partnership (the “Operating Partnership”), IAS ASSET I LLC, a Delaware limited liability company (“Asset I”) and INVESCO ADVISERS, INC., a Delaware corporation (formerly Invesco Institutional (N.A.), Inc., the “Manager”).

WHEREAS, on July 1, 2009, the Company, the Operating Partnership, Asset I and the Manager entered into that certain management agreement (the “Agreement”) whereby the Manager was retained to provide investment advisory services to the Company, the Operating Partnership, Asset I and any of their Subsidiaries;

WHEREAS, on May 24, 2011, the parties entered into an amendment to the Agreement; and

WHEREAS, the parties desire to further amend the Agreement; 

NOW THEREFORE, in consideration of the mutual agreements herein set forth, the parties hereto agree as follows:

Section 1.    Definitions.  All terms not defined herein shall have the meaning given to it in the Agreement.

Section 2.    Amendment.  Section 1(ii) of the Agreement shall be deleted in their entirety and replaced with the following:

“(ii)    “Stockholders’ Equity” means:

(i) the sum of the net proceeds from all issuances of the Company’s equity securities since inception (allocated on a pro rata daily basis for such issuances during the fiscal quarter of any such issuance), plus

(ii) the Company’s retained earnings at the end of the most recently 
completed calendar quarter (without taking into account any non-cash equity compensation expense incurred in current or prior periods), less

(iii) any amount that the Company pays for repurchases of its common stock since inception.

Stockholders’ Equity shall exclude (a) any unrealized gains, losses or other items that do not
affect realized net income (regardless of whether such items are included in other comprehensive income or loss, or in net income), (b) cumulative net realized losses that are not attributable to 

permanently impaired investments and that relate to investments for which market movement is accounted for in other comprehensive income, provided, however, that such adjustment shall not exceed cumulative unrealized net gains in other comprehensive income, and (c) one-time events pursuant to changes in GAAP and certain non-cash items after discussions between the Manager and the Company’s Independent Directors and approval by a majority of the Company’s Independent Directors.

For purposes of calculating Stockholders’ Equity, outstanding limited partner interests in the
Operating Partnership (other than the limited partner interests held by the Company) shall be treated as outstanding shares of capital stock of the Company.”

Section 3.    Continued Effect of Agreement.  Except as specifically amended by this Amendment, the Agreement remains unaffected and continues in full force and effect as though completely restated in this Amendment.

Section 4.    Interpretation of Amendment.  In the event of any conflict, inconsistency or incongruity between any term or condition of this Amendment and any term or condition of the Agreement, the term of this Amendment shall govern and control.

Section 5.    Governing Law.  This Amendment shall be governed by, and construed and interpreted in accordance with, the law of the State of New York, without regard to conflicts of law principles to the contrary.

Section 6.    No Waiver; Cumulative Remedies.  No failure to exercise and no delay in exercising, on the part of any party hereto, any right, remedy, power or privilege hereunder shall operate as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege.  The rights, remedies, powers and privileges herein provided are cumulative and not exclusive of any rights, remedies, powers and privileges provided by law.  No waiver of any provision hereunder shall be effective unless it is in writing and is signed by the party asserted to have granted such waiver.

Section 7.    Headings.  The headings of the sections of this Amendment have been inserted for convenience of reference only and shall not be deemed part of this Amendment. 

Section 8.    Counterparts.  This Amendment may be executed in any number of counterparts, each of which shall be deemed to be an original as against any party whose signature appears thereon, and all of which shall together constitute one and the same instrument.  This Amendment shall become binding when one or more counterparts of this Amendment, individually or taken together, shall bear the signatures of all of the parties reflected hereon as the signatories.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first written above.

INVESCO MORTGAGE CAPITAL INC.

By:/s/ Richard Lee Phegley, Jr._________
     Name: Richard Lee Phegley, Jr.
     Title:     Chief Financial Officer

IAS OPERATING PARTNERSHIP L.P.

By:    Invesco Mortgage Capital Inc., as its general partner

By:/s/ Richard Lee Phegley, Jr._________
     Name: Richard Lee Phegley, Jr.
     Title:     Chief Financial Officer

IAS ASSET I LLC

By:   IAS Operating Partnership L.P., as its sole member

By:   Invesco Mortgage Capital Inc., as its general partner

By:/s/ Richard Lee Phegley, Jr._________
     Name: Richard Lee Phegley, Jr.
     Title:     Chief Financial Officer

INVESCO ADVISERS, INC.

By: /s/ Richard J. King________________
     Name: Richard J. King
     Title:     Vice President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00248-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00248-of-00352.parquet"}]]